Stempoint Capital »

Equillium shares owned by Stempoint Capital

Quarter-by-quarter ownership of Equillium (EQ) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Equillium

Tip: Access up to 7 years of quarterly data

All positions including Equillium held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Equillium by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.7M 1.9M 1.43

More positions owned by Stempoint Capital

Roivant Sciences SHS (ROIV)
Uniqure Nv SHS (QURE)
Immunovant (IMVT)
Scholar Rock Hldg Corp (SRRK)
Denali Therapeutics (DNLI)
Syndax Pharmaceuticals (SNDX)
Biohaven (BHVN)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Wave Life Sciences SHS (WVE)
Cidara Therapeutics Com New (CDTX)
Abivax Sa Sponsored Ads (ABVX)
Ideaya Biosciences (IDYA)
Rhythm Pharmaceuticals (RYTM)
Argenx Se Sponsored Adr (ARGX)
Surrozen Com New (SRZN)

View all positions for Stempoint Capital

Top funds holding Equillium

ADAR1 Capital Management
Adage Capital Partners GP
Decheng Capital
Woodline Partners
Balyasny Asset Management
Stempoint Capital
Takeda Pharmaceutical
Vanguard Group
Renaissance Technologies
Cantor Fitzgerald, L. P.
Standard Life Aberdeen
Ikarian Capital
Geode Capital Management
Diadema Partners
Hudson Bay Capital Management

View all funds holding Equillium